Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score.

FR Appelbaum, J Anderson - Leukemia (08876924), 1998 - search.ebscohost.com
marrow transplantation for MDS.'' A total of 516 patients with MDS undergoing bone marrow
transplantation … After a median follow-up of 1-6 years, there are 209 (41 "/.i) reported disease-…

Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS

T De Witte, A Van Biezen, J Hermans… - Blood, The Journal …, 1997 - ashpublications.org
… autologous bone marrow transplantation (ABMT) may provide an alternative therapy for
young patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (…

Myelodysplastic syndrome

G Mufti, AF List, SD Gore, AYL Ho - ASH Education Program …, 2003 - ashpublications.org
… Aloysius Ho describe the role of bone marrow transplantation with particular emphasis
on recent results from reduced-intensity conditioned transplants, exploiting the graft versus …

Bone marrow transplantation for myelodysplastic syndrome–who? when? and which?

S Luger, N Sacks - Bone marrow transplantation, 2002 - nature.com
… While bone marrow transplantation should always be considered in the management of
a patient with myelodysplastic syndrome, we must continue to try and improve upon the …

Myelodysplastic syndrome

WK Hofmann, HP Koeffler - Annu. Rev. Med., 2005 - annualreviews.org
MDS is a clonal disorder characterized by ineffective … ) of the MDS patients and the individual
history of the disease (number … Allogeneic bone marrow transplantation currently offers the …

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

HJ Deeg, HM Shulman, JE Anderson… - Blood, The Journal …, 2000 - ashpublications.org
marrow transplantation for MDS is associated with considerable clinical toxicity in patients of
all ages. However, our results with hemopoietic stem-cell transplantation … for transplantation

Diagnosis and treatment of myelodysplastic syndromes: a review

MA Sekeres, J Taylor - Jama, 2022 - jamanetwork.com
… A separate observational study from the Center for International Bone Marrow Transplant
Research reported similar overall survival for patients aged 55 to 64 years compared with …

[HTML][HTML] Myelodysplastic syndromes: diagnosis, prognosis, and treatment

U Germing, G Kobbe, R Haas… - Deutsches Ärzteblatt …, 2013 - ncbi.nlm.nih.gov
Myelodysplastic syndromes are treated on an individualized, risk-… The myelodysplastic
syndromes (MDS) are among the … The incidence of MDS rises sharply with advancing age, …

… decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with …

CS Cutler, SJ Lee, P Greenberg, HJ Deeg, WS Pérez… - Blood, 2004 - ashpublications.org
… Because the optimal timing of HLA-matched BMT for MDS is unknown, we constructed …
transplantation strategies for newly diagnosed MDS: transplantation at diagnosis, transplantation

Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program

H Castro-Malaspina, RE Harris… - Blood, The Journal …, 2002 - ashpublications.org
… The study population consisted of 510 patients with MDS who received marrow transplants
at 87 NMDP-approved transplantation centers (76 in the United States and 11 in Canada, …